Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HELIOS UNDERWRITING PLC Director's Dealing 2024

Jun 3, 2024

7691_dirs_2024-06-03_9d5c7f82-9e7d-4a25-9c68-fe17e9ac7392.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9169Q

Helios Underwriting Plc

03 June 2024

3 June 2024

Helios Underwriting plc

("Helios" or the "Company")

Director's Shareholding

Helios, the investment vehicle which builds shareholder value through exposure to Lloyd's, was informed on 31 May 2024 that Mr Nigel Hanbury, Executive Deputy Chairman and Director of the Company and persons closely associated with Mr Hanbury, on the same day, sold 47,600 ordinary shares of 10 pence each ("Ordinary Shares") at a price of 170 pence per share and subsequently purchased 46,400 Ordinary Shares at a price of 170 pence per share and 1,200 Ordinary Shares at a price of 175 pence per share. Mr Hanbury's total interest remains unchanged at 9,448,419 Ordinary Shares, representing 12.64% of the issued share capital of the Company.

The notifications below, which has been made in accordance with the requirement of the EU Market Abuse Regulation, provide further details.

For further information, please contact:

Helios Underwriting plc

Martin Reith - CEO                                                       +44 (0) 203 965 6441

Nigel Hanbury - Executive Deputy Chairman         

Arthur Manners - Chief Financial Officer                

Deutsche Numis (Nomad and Broker)                                        

Giles Rolls / Charles Farquhar                                     +44 (0)20 7260 1000

FTI Consulting 

Ed Berry

Nathan Hambrook-Skinner

Tom O'Brien
+44 (0)7703 330 199

+44 (0)7977 817 092

+44 (0)7929 021 492

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £502m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Hanbury (Director)

Elizabeth Hanbury (PCA)

Clementine Hanbury (PCA)

George Hanbury (PCA)

2

Reason for the notification

a)

Position/status

Director

PCA

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Helios Underwriting Plc

b)

LEI

213800FX86DJW5TCM864

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each

ISIN - GB00B23XLS45

b)

Nature of the transaction

On market sale and purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
Sale: 170p 11,900
Sale: 170p 11,900
Sale: 170p 11,900
Sale: 170p 11,900
Purchase: 170p 11,600
Purchase: 170p 11,600
Purchase: 170p 11,600
Purchase: 170p 11,600
Purchase: 175p 300
Purchase: 175p 300
Purchase: 175p 300
Purchase: 175p 300

d)

Aggregated information

Price(s) Volume(s)
Sale: 170p 47,600
Purchase: 170p 46,400
Purchase: 175p 1,200

e)

Date of the transaction

31 May 2024

f)

Place of the transaction    

London Stock Exchange, AIM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHQKNBDQBKDFAK